Standout Papers
- Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas (2016)
- Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial (2022)
Immediate Impact
4 by Nobel laureates 18 from Science/Nature 59 standout
Citing Papers
Visible Light-Induced Reactions of Diazo Compounds and Their Precursors
2024 Standout
Expanding chemistry through in vitro and in vivo biocatalysis
2024 StandoutNature
Works of Yu Zhou being referenced
Visible light-induced synthesis of 1,3-disubstituted bicyclo[1.1.1]pentane ketonesviacooperative photoredox and N-heterocyclic carbene catalysis
2023
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yu Zhou | 5090 | 1489 | 1044 | 2008 | 202 | 7.4k | |
| Kenneth L. Kirk | 3179 | 2190 | 693 | 2394 | 182 | 7.4k | |
| Takamitsu Hosoya | 5098 | 2755 | 372 | 857 | 266 | 8.1k | |
| Hong Yi | 7542 | 1364 | 957 | 545 | 218 | 10.1k | |
| Wei Wang | 7897 | 2499 | 1564 | 799 | 305 | 10.7k | |
| Steven H. Liang | 2600 | 1134 | 370 | 1064 | 152 | 5.5k | |
| Hiroaki Ohno | 7000 | 2180 | 740 | 441 | 309 | 9.4k | |
| Jón T. Njardarson | 10661 | 2105 | 1569 | 1223 | 114 | 12.6k | |
| Mikiko Sodeoka | 9286 | 4366 | 3451 | 4189 | 306 | 15.0k | |
| Matteo Zanda | 2705 | 1768 | 426 | 1597 | 209 | 4.5k | |
| Choon‐Hong Tan | 7026 | 2352 | 1793 | 724 | 196 | 10.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...